TOP TIERMARKET NEWSWIRE

News & sentiment

REGENXBIO INC (RGNX) — News & AI sentiment

REGENXBIO INC (RGNX) news roundup. 2 stories in the past week, 30 over 30 days. Average 30-day sentiment is 42.8/100. Recent insider activity (SEC Form 4, 90-day window): 1 purchases totalling $949K and 2 sales totalling $718K — net buying of $231K. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →

24h stories

0

7d stories

2

avg sentiment 59.5/100

30d stories

30

avg sentiment 42.8/100

Insider net (90d)

$231K

1 buys · 2 sells

Congress (90d)

0

0 buys · 0 sells

RGNX news in the last 24 hours, 7 days, 30 days and 90 days

How much RGNX coverage the wire captured in each window, with the average AI sentiment across those stories. Counts are of stories that have cleared the 4-hour public delay.

Time window	RGNX stories	Avg AI sentiment	Read
Last 24 hours	0	—	no coverage
Last 7 days	2	59.5/100	RGNX headlines →
Last 30 days	30	42.8/100	RGNX headlines →
Last 90 days	73	48.7/100	RGNX headlines →

Latest stories on RGNX

Wet Age-Related Macular Degeneration Market Emerging as a High-Growth Healthcare Investment Space Through 2036 – DelveInsight | Opthea Limited, Regenxbio, Alkahest, Graybug Vision, Alcon Research

Barchart63 · neutralgeneral

1d ago

REGENXBIO to Participate in Upcoming Investor Conferences

PR Newswire56 · neutralgeneral

5d ago

Regenxbio rises on new director stock purchase

Seeking Alpha58 · neutralgeneral

Aug 28

Regenxbio stock surges on director share purchases

Investing.com Markets63 · neutralgeneral

Aug 28

Regenxbio director buys $949.4K in common stock

The Fly56 · neutralgeneral

Aug 27

H.C. Wainwright cuts Regenxbio stock price target on clinical hold

Investing.com Analyst Ratings34 · bearishanalyst

Aug 26

RegenXBio reshapes board with new independent director

TipRanks55 · neutralgeneral

Aug 25

REGENXBIO Inc. (RGNX) files 8-K

SEC 8-K50 · neutralgeneral

Aug 25

Regenxbio price target lowered to $21 from $23 at H.C. Wainwright

The Fly42 · neutralanalyst

Aug 25

Regenxbio: Sell-Off On Hunter Setback Presents A Risky Buy Opportunity

Seeking Alpha54 · neutralanalyst

Aug 25

REGENXBIO Strengthens Board of Directors with Appointment of Greg Ciongoli

PR Newswire55 · neutralgeneral

Aug 25

Regenxbio’s RGX-121 Setback Carries A Potential Cash Risk, Warns Clear Street

Stocktwits News32 · bearishgeneral

Aug 25

Regenxbio price target lowered to $29 from $32 at Baird

The Fly42 · neutralanalyst

Aug 25

Regenxbio price target lowered to $32 from $45 at Clear Street

The Fly34 · bearishanalyst

Aug 25

RegenXBio Faces RGX-121 Clinical Hold, Refocuses Pipeline

TipRanks34 · bearishgeneral

Aug 24

REGENXBIO Inc. (RGNX) files 8-K

SEC 8-K50 · neutralgeneral

Aug 24

RGNX Stock On Track For Worst Day In Over Three Months — BofA Says Buy Despite ‘Disappointing’ FDA Hold On Gene Therapy

Stocktwits News48 · neutralanalyst

Aug 24

RGNX Investor Notice: Johnson Fistel Investigates REGENXBIO Inc. Following Clinical Hold

GlobeNewswire34 · bearishgeneral

Aug 24

BofA says Regenxbio’s MPS setback ‘disappointing,’ larger catalysts intact

The Fly38 · neutralgeneral

Aug 24

Why Regenxbio Halted Its Gene Therapy Trial—and Why the Stock Is Tumbling

Barron's28 · bearishgeneral

Aug 24

Morning Movers: Regenxbio sinks following clinical hold on RGX-121

The Fly32 · bearishproduct/pr

Aug 24

Why Did RGNX Stock Crash Today?

Stocktwits News28 · bearishgeneral

Aug 24

REGENXBIO Shares Plunge After FDA Places Clinical Hold on RGX-121

InvestorsHub22 · bearishproduct/pr

Aug 24

Regenxbio Stock Sinks 22% Following Surprise Finding in Gene Therapy Trial

Barron's28 · bearishproduct/pr

Aug 24

Regulatory Hold on REGENXBIO’s RGX-121 Shifts Focus to Duchenne and Retinal Therapies Amid Benign MRI Findings August 24, 2026

MarketChameleon42 · neutralgeneral

Aug 24

Open RGNX in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →